Adcock Ingram Holdings Ltd (AIP) – Strategy, SWOT and Corporate Finance Report

Adcock Ingram Holdings Ltd (AIP) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, cough, central nervous system, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It has manufacturing facilities in South Africa and a manufacturing facility in Bangalore, India. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Johannesburg, South Africa.

Scope

• Detailed information on Adcock Ingram Holdings Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Adcock Ingram Holdings Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Adcock Ingram Holdings Ltd including a breakdown and examination of key business segments

• News about Adcock Ingram Holdings Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Adcock Ingram Holdings Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Adcock Ingram Holdings Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Adcock Ingram Holdings Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

SA Natural Products (Pty) Ltd

Buka Investments Ltd

Starwin Products Ltd

Rosemont Pharmaceuticals Ltd

Nutritional Holdings Ltd

Natural Carotenoids South Africa (Pty) Ltd

Herbal Africa

Aspen Pharmacare Holdings Ltd

Ascendis Health Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Adcock Ingram Holdings Ltd - Key Facts

Adcock Ingram Holdings Ltd - Key Employees

Adcock Ingram Holdings Ltd - Key Employee Biographies

Adcock Ingram Holdings Ltd - Major Products and Services

Adcock Ingram Holdings Ltd - History

Adcock Ingram Holdings Ltd - Company Statement

Adcock Ingram Holdings Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Adcock Ingram Holdings Ltd - Business Description

Business Segment: Consumer

Overview

Performance

Business Segment: Hospital

Overview

Performance

Business Segment: OTC

Overview

Performance

Business Segment: Other, shared services

Performance

Business Segment: Prescription

Overview

Performance

Adcock Ingram Holdings Ltd - Corporate Strategy

Adcock Ingram Holdings Ltd - SWOT Analysis

SWOT Analysis - Overview

Adcock Ingram Holdings Ltd - Strengths

Adcock Ingram Holdings Ltd - Weaknesses

Adcock Ingram Holdings Ltd - Opportunities

Adcock Ingram Holdings Ltd - Threats

Adcock Ingram Holdings Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Adcock Ingram Holdings Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 23, 2023: Adcock Ingram Delivers Healthy Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Adcock Ingram Holdings Ltd, Key Facts

Adcock Ingram Holdings Ltd, Key Employees

Adcock Ingram Holdings Ltd, Key Employee Biographies

Adcock Ingram Holdings Ltd, Major Products and Services

Adcock Ingram Holdings Ltd, History

Adcock Ingram Holdings Ltd, Subsidiaries

Adcock Ingram Holdings Ltd, Joint Venture

Adcock Ingram Holdings Ltd, Key Competitors

Adcock Ingram Holdings Ltd, Ratios based on current share price

Adcock Ingram Holdings Ltd, Annual Ratios

Adcock Ingram Holdings Ltd, Annual Ratios (Cont…1)

Adcock Ingram Holdings Ltd, Annual Ratios (Cont…2)

Adcock Ingram Holdings Ltd, Interim Ratios

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Adcock Ingram Holdings Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Adcock Ingram Holdings Ltd, Performance Chart (2019 – 2023)

Adcock Ingram Holdings Ltd, Ratio Charts

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports